Elanco Animal Health (ELAN) Osake Kurssi
Elanco Animal Health Kurssi
Viimeisten 12 vuoden aikana Elanco Animal Healthn liikevaihto kasvoi 7,7 % vuodessa ja ylsi 4,72 Mrd. USD:een. Osakekohtainen tulos on kasvanut 2,2 % vuodessa viimeisten 11 vuoden aikana. Elanco Animal Healthn nettomarginaali −4,9 % on noussut verrattuna −10,1 %:iin muutama vuosi sitten. Elanco Animal Healthn 12 kuukauden konsensustavoitehinta on 30,00 USD, noin yli kurssia 22,1 %. 22 analyytikosta 19 suosittaa ostoa — kokonaiskonsensus on Osta.
Elanco Animal Health osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Elanco Animal Health liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Elanco Animal Health -osakkeesta
The business model of Elanco Animal Health Inc is focused on providing comprehensive solutions for animal health and welfare. Elanco develops and manufactures a wide range of pharmaceutical products, vaccines, and nutritional products for both companion animals and livestock. The company aims to improve the health and well-being of animals by delivering innovative solutions that enhance their productivity and quality of life. Elanco's business model operates through research and development, manufacturing, marketing, and sales of animal health products globally. With a commitment to innovation and sustainability, Elanco Animal Health is dedicated to supporting the welfare of animals and the needs of their owners.
Elanco Animal Health Inc is primarily active in the animal health industry.
The main competitors of Elanco Animal Health Inc in the market include Zoetis Inc, Merck Animal Health, and Boehringer Ingelheim.
Elanco Animal Health Inc, a leading animal health company, has a rich history and background. Established in 1954 as a division of Eli Lilly and Company, Elanco has grown into a standalone company dedicated to improving animal health and well-being. With a wide portfolio of products and services, Elanco offers solutions for livestock and pets, encompassing pharmaceuticals, vaccines, and medicated feed additives. The company's commitment to innovation and research has positioned it as a global leader in animal health, addressing the evolving needs of the industry. Elanco Animal Health Inc continues to advance animal health through sustainable practices and partnerships, ensuring healthier and happier animals worldwide.
Elanco Animal Health Inc has achieved several significant milestones in its history. Since its inception, the company has focused on improving animal health through its innovative products and solutions. One major milestone was its spin-off from Eli Lilly and Company in 2018, establishing Elanco as a standalone company dedicated solely to animal health. Elanco has continually expanded its portfolio of products and services, helping to address the diverse needs of farmers and veterinarians worldwide. Through strategic acquisitions and collaborations, the company has strengthened its position in the animal health industry. Moreover, Elanco's commitment to sustainability and responsible animal care has garnered recognition, earning it a place among the industry leaders.
Elanco Animal Health Inc is primarily present in multiple countries and regions worldwide. As a global company, Elanco operates in various parts of North America, including the United States and Canada. It also maintains a significant presence in Europe, with operations in several countries such as Germany, France, Spain, Italy, and the United Kingdom. Additionally, Elanco has a strong foothold in the Asia-Pacific region, with a focus on countries like China, Japan, Australia, and India. The company's broad international presence allows Elanco Animal Health Inc to cater to the diverse needs of animal health across different markets, showcasing its commitment to global growth and innovation.
Elanco Animal Health Inc represents a strong commitment to improving animal health and welfare. Their corporate philosophy is rooted in the belief that healthy animals contribute to a better world for both animals and humans. They strive to deliver innovative solutions and products that address the diverse needs of animals, including their nutrition, health, and well-being. Elanco Animal Health Inc is dedicated to ensuring the responsible and ethical use of their products, while providing exceptional value to their customers. They aim to foster strong partnerships within the animal health industry and continuously work towards advancements in animal care and sustainability.
Analyytikot asettavat tällä hetkellä Elanco Animal Health-osakkeelle keskimääräisen tavoitehinnan 28,67 USD (mediaani: 30,00 USD), mikä merkitsee +16,7 % viimeisimpään hintaan verrattuna. Konsensus perustuu 22 analyytikkoarvioon.
22 analyytikkoa arvioi tällä hetkellä Elanco Animal Health-osaketta: 19 suosittaa ostoa, 3 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Elanco Animal Health-yhtiöltä 5,14 Mrd. USD liikevaihtoa ja 1,13 USD osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Elanco Animal Health-osake noteerataan hintaan 21,95 EUR (24,57 USD).
Elanco Animal Health-osake (ELAN) on listattuna 5 pörssissä, muun muassa: NYSE (ELAN), XETRA (5EA.DE), Frankfurt (5EA.F), München (5EA.MU), Düsseldorf (5EA.DU).
Elanco Animal Health Inc. is a global company that focuses on researching, developing, manufacturing, and marketing products and solutions for animal health. The company offers a wide range of products in the areas of animal health, animal nutrition, and animal production, and serves customers in over 90 countries worldwide.
odotettu liikevaihto Elanco Animal Health on 5,14 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Elanco Animal Health on 563,08 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Elanco Animal Health:n hinta-voitto-suhde (P/E) on tällä hetkellä 21,68. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Elanco Animal Health-osakkeen arvostusta.
Elanco Animal Health:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,38. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Elanco Animal Health-osakkeen arvostuskennuslukuna.
Elanco Animal Health:n Eulpool-laatuscore on 1/10.
Elanco Animal Health:n ISIN on US28414H1032. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Elanco Animal Health:n WKN on A2N6BH. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Elanco Animal Health:n ticker on ELAN. Tämä pörssinoteeraus käytetään Elanco Animal Health-osakkeiden kauppaan pörssissä.
Elanco Animal Health osake
Elanco Animal Health vertaisryhmä
Elanco Animal Health Ticker
Elanco Animal Health FIGI
Kaikki tunnusluvut ja syvällinen analyysi Elanco Animal Health:sta
Meidän osakeanalyysimme Elanco Animal Health-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Elanco Animal Health:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: